CD4 and lymphedema: The study found that CD4+T cells contribute to lymphangiogenesis are activated in regional lymph nodes and migrate to the skin to initiate lymphedema which demonstrates that the CD4+T cell is a potential therapeutic target for the prevention of lymphedema (112, 116, 156).